Quantcast

Latest keratoconus Stories

2009-07-20 07:15:00

CARLSBAD, Calif., July 20 /PRNewswire/ -- SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providing superior visual acuity, centration, stability, and all-day comfort. The patent-pending design is optimized to vault the predominant irregularities of the keratoconic cornea, thus effectively...

2009-07-01 08:34:20

The July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions. One study reports on silent cerebral infarcts (SCI) incidence and visual field loss in patients with normal-tension glaucoma; the other correlates inflammation biomarkers with corneal transplant rejection in herpes simplex patients.Silent Cerebral Infarcts: Risk Factor for Visual Field Loss as Well as for Stroke?Health...

2009-03-11 06:50:00

CARLSBAD, Calif., March 11 /PRNewswire/ -- SynergEyes, Inc., the developer of the first FDA-cleared hybrid contact lens specifically designed for patients with keratoconus, has launched a new educational website (http://www.SharingOneVision.com) for patients seeking information on the eye disease keratoconus and treatment with hybrid contact lenses. Keratoconus is a highly debilitating eye condition in which the cornea thins and becomes cone-shaped and irregular rather than spherical like a...

2009-03-03 05:00:00

LOS ANGELES, March 3 /PRNewswire/ -- Dr. Brian S. Boxer Wachler, MD, a world-renowned eye surgeon and the director of the Boxer Wachler Vision Institute in Beverly Hills, California, announced today that he has developed a new procedure that uses vitamin applications to treat Keratoconus, an often devastating condition that can lead to legal blindness in patients. Dr. Boxer Wachler's new treatment, C3-R(R) (corneal collagen cross-linking with riboflavin) is the first vision correction...

2009-02-06 07:15:00

CARLSBAD, Calif., Feb. 6 /PRNewswire/ -- SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, announced today the closing of $13.3 million in Series C financing to fund the development and clinical trials for next-generation hybrid contact lens products and to expand sales and marketing efforts globally. De Novo Ventures of Palo Alto, CA, led this round as well as SynergEyes' Series B round. Bio-Star Private Equity Fund joined Series A and B investors: Alloy Ventures, Delphi...

2008-12-11 11:32:00

Seeing Well at 100! WEST ORANGE, N.J., Dec. 11 /PRNewswire/ -- On October 29, 2008, Katherine L. Rummler celebrated her 100th birthday. This year, to her great joy, she was able to experience her birthday with good vision. Recently Katherine had DSEK, a partial corneal transplant that has a much shorter recovery time than a traditional transplant, performed by Dr. Theodore Perl of Corneal Associates of New Jersey. Katherine, who still lives in the house her parents had built in 1918, has...

2008-11-11 18:00:20

Strong turnout and a robust scientific program marked the largest and most comprehensive ophthalmic educational meeting in the world, the American Academy of Ophthalmology's (Academy) 2008 Joint Meeting in conjunction with the European Society of Ophthalmology (SOE), held in Atlanta November 8 to November 11. Preliminary figures for attendance at the meeting were approximately 22,000. Among the offerings featured at the meeting were 277 instruction courses, 79 "Breakfast with the Expert"...

2008-09-30 18:01:15

By LIZA WILLIAMS HUNDREDS of Liverpool students have signed up to become organ donors after the launch of an NHS campaign in the city. A roadshow aimed at new students visited John Moores University earlier this month, and more than 250 people signed up to the Organ Donor Register (ODR). The Superhero campaign is continuing online to encourage more students to register. Ph.D student Philip Widdowson, 23, knows first hand the importance of donors. The Liverpudlian who is studying...

2008-08-05 15:00:11

DEAR DR. DONOHUE: My son, 50, has been diagnosed with Graves disease. Will you define the condition and its treatment? I am very concerned for him. - J.C. ANSWER: Graves disease is the No. 1 cause of an overactive thyroid gland - hyperthyroidism. It happens because the immune system, for reasons not clear, makes antibodies that stimulate the thyroid gland. Antibodies usually are used to fight germs. Not in this case. These special antibodies prod the thyroid gland into overproduction of...

2005-08-01 18:40:40

Bethesda, MD "“ An international group of researchers has characterized the proteome of the human cornea. In doing so, they have identified 141 distinct proteins, 99 of which had not been previously recognized in mammalian corneas. The details of their findings appear in the August/September issue of Molecular and Cellular Proteomics, an American Society for Biochemistry and Molecular Biology journal. The cornea is the transparent, dome-shaped window that covers the front of the eye....


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.